D5W Placebo: Clinical Trials

3 trials of D5W Placebo, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 unknown. 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 2, Unknown 1
Phase 21Completed 1

Follow D5W Placebo: new trials by email Literature Review of D5W Placebo trials Research Report on D5W Placebo

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Plinabulin vs. Pegfilgrastim in Prevention of TAC Induced Neutropenia
Pegfilgrastim, Plinabulin, D5W Placebo - Chemotherapy-induced Neutropenia
Phase 3UnknownBeyondSpring Pharmaceuticals Inc.2212019-10-232021-01-15
Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 3
Plinabulin, Pegfilgrastim, Saline Placebo - Chemotherapy-induced Neutropenia
Phase 3CompletedBeyondSpring Pharmaceuticals Inc.1052018-05-292024-08-29
N-Acetylcysteine in Critically Ill Patients Undergoing Contrast Enhanced Computed Tomography
N-acetylcysteine, D5W Placebo - Contrast Induced Nephropathy, Critically Ill
Phase 2 / Phase 3CompletedUnity Health Toronto452002-08-012009-01-27

Conditions studied

Critical Illness (1)

Sponsors

BeyondSpring Pharmaceuticals Inc. (2)  ·  Unity Health Toronto (1)

Countries

China (2)  ·  Ukraine (2)  ·  Canada (1)  ·  Russia (1)  ·  United States (1)

Top investigators

Claudio M Martin, MD, FRCPC, MSc (1)  ·  Douglas Blayney, M.D. (1)  ·  Douglas W. Blayney, MD (1)

Results publications

PMID 32970104, PMID 35084480